- terrycollins1
- September 9, 2009
Health biotech firms with developing country partners better postitioned to innovate, prosper
McLaughlin-Rotman Centre for Global Health 9 Sep 2009 Lower manufacturing, clinical trial, R&D costs of developing country partners equal major opportunities to advance global health,
